Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, BKH, MURA, SCPH on Behalf of Shareholders

BKH, NWE

NEW YORK, Aug. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

NorthWestern Energy Group, Inc. (NASDAQ: NWE)'s sale to Black Hills Corp. for 0.98 shares of Black Hills for each share of NorthWestern. Upon completion of the proposed transaction, NorthWestern shareholders will own approximately 44% of the combined company. If you are a NorthWestern shareholder, click here to learn more about your rights and options.

Black Hills Corp. (NYSE: BKH)'s merger with NorthWestern Energy Group, Inc. Upon completion of the proposed transaction, Black Hills shareholders will own approximately 56% of the combined company. If you are a Black Hills shareholder, click here to learn more about your rights and options.

Mural Oncology plc (NASDAQ: MURA)'s sale to XOMA Royalty Corporation for $2.035 per share and up to an additional $0.205 per share under certain conditions. If you are a Mural shareholder, click here to learn more about your rights and options.

scPharmaceuticals Inc. (NASDAQ: SCPH)'s sale to MannKind Corporation. Under the terms of the proposed transaction, scPharmaceuticals shareholders would receive a cash payment of $5.35 per share plus one non-tradable contingent value right (CVR) per share payable upon achieving specific regulatory and net sales milestones worth up to $1.00 per CVR in cash. If you are a scPharmaceuticals shareholder, click here to learn more about your legal rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-nwe-bkh-mura-scph-on-behalf-of-shareholders-302541017.html

SOURCE Halper Sadeh LLP